Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 130

Similar articles for PubMed (Select 19149544)

1.

mTOR in growth and protection of hypertrophying myocardium.

Balasubramanian S, Johnston RK, Moschella PC, Mani SK, Tuxworth WJ Jr, Kuppuswamy D.

Cardiovasc Hematol Agents Med Chem. 2009 Jan;7(1):52-63. Review.

PMID:
19149544
2.

Mammalian target of rapamycin: discovery of rapamycin reveals a signaling pathway important for normal and cancer cell growth.

Gibbons JJ, Abraham RT, Yu K.

Semin Oncol. 2009 Dec;36 Suppl 3:S3-S17. doi: 10.1053/j.seminoncol.2009.10.011. Review.

PMID:
19963098
3.
4.

Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton.

Sarbassov DD, Ali SM, Kim DH, Guertin DA, Latek RR, Erdjument-Bromage H, Tempst P, Sabatini DM.

Curr Biol. 2004 Jul 27;14(14):1296-302.

5.

Activation or inactivation of cardiac Akt/mTOR signaling diverges physiological from pathological hypertrophy.

Kemi OJ, Ceci M, Wisloff U, Grimaldi S, Gallo P, Smith GL, Condorelli G, Ellingsen O.

J Cell Physiol. 2008 Feb;214(2):316-21.

PMID:
17941081
6.

Inhibition of mTOR signaling with rapamycin regresses established cardiac hypertrophy induced by pressure overload.

McMullen JR, Sherwood MC, Tarnavski O, Zhang L, Dorfman AL, Shioi T, Izumo S.

Circulation. 2004 Jun 22;109(24):3050-5. Epub 2004 Jun 7.

7.

mTORC2 activity is elevated in gliomas and promotes growth and cell motility via overexpression of rictor.

Masri J, Bernath A, Martin J, Jo OD, Vartanian R, Funk A, Gera J.

Cancer Res. 2007 Dec 15;67(24):11712-20.

8.

Nutrient-dependent multimerization of the mammalian target of rapamycin through the N-terminal HEAT repeat region.

Takahara T, Hara K, Yonezawa K, Sorimachi H, Maeda T.

J Biol Chem. 2006 Sep 29;281(39):28605-14. Epub 2006 Jul 26.

9.

P-Rex1 links mammalian target of rapamycin signaling to Rac activation and cell migration.

Hernández-Negrete I, Carretero-Ortega J, Rosenfeldt H, Hernández-García R, Calderón-Salinas JV, Reyes-Cruz G, Gutkind JS, Vázquez-Prado J.

J Biol Chem. 2007 Aug 10;282(32):23708-15. Epub 2007 Jun 12.

10.

The functions of mTOR in ischemic diseases.

Hwang SK, Kim HH.

BMB Rep. 2011 Aug;44(8):506-11. Review.

11.

The mammalian target of rapamycin-signaling pathway in regulating metabolism and growth.

Yang X, Yang C, Farberman A, Rideout TC, de Lange CF, France J, Fan MZ.

J Anim Sci. 2008 Apr;86(14 Suppl):E36-50. Epub 2007 Nov 12. Review.

12.

Rapamycin attenuates load-induced cardiac hypertrophy in mice.

Shioi T, McMullen JR, Tarnavski O, Converso K, Sherwood MC, Manning WJ, Izumo S.

Circulation. 2003 Apr 1;107(12):1664-70. Epub 2003 Mar 17.

13.

Protein turnover in cardiac cell growth and survival.

Hedhli N, Pelat M, Depre C.

Cardiovasc Res. 2005 Nov 1;68(2):186-96. Epub 2005 Aug 2. Review.

14.

Nutrient-responsive mTOR signalling grows on Sterile ground.

Cook SJ, Morley SJ.

Biochem J. 2007 Apr 1;403(1):e1-3.

15.

Rheb activates protein synthesis and growth in adult rat ventricular cardiomyocytes.

Wang Y, Huang BP, Luciani DS, Wang X, Johnson JD, Proud CG.

J Mol Cell Cardiol. 2008 Dec;45(6):812-20. doi: 10.1016/j.yjmcc.2008.07.016. Epub 2008 Aug 3.

PMID:
18722381
16.

Monitoring mammalian target of rapamycin (mTOR) activity.

Ikenoue T, Hong S, Inoki K.

Methods Enzymol. 2009;452:165-80. doi: 10.1016/S0076-6879(08)03611-2.

PMID:
19200882
17.

Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive.

Jacinto E, Loewith R, Schmidt A, Lin S, Rüegg MA, Hall A, Hall MN.

Nat Cell Biol. 2004 Nov;6(11):1122-8. Epub 2004 Oct 3.

PMID:
15467718
18.

Rapamycin regulates the phosphorylation of rictor.

Akcakanat A, Singh G, Hung MC, Meric-Bernstam F.

Biochem Biophys Res Commun. 2007 Oct 19;362(2):330-3. Epub 2007 Aug 8.

19.

Antineoplastic effect of proliferation signal inhibitors: from biology to clinical application.

Bertoni E, Salvadori M.

J Nephrol. 2009 Jul-Aug;22(4):457-62. Review.

PMID:
19662600
20.

Ras, PI3-kinase and mTOR signaling in cardiac hypertrophy.

Proud CG.

Cardiovasc Res. 2004 Aug 15;63(3):403-13. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk